Actively Recruiting
Evaluating Cannabidiol CBD as an Additional Treatment for Alcohol Withdrawal Symptoms and Craving in Adults with Alcohol Use Disorder
Led by Johns Hopkins University · Updated on 2026-11-03
105
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the use of cannabidiol CBD, a common component of cannabis, as a possible treatment to reduce alcohol withdrawal symptoms and cravings in adults with moderate-to-severe Alcohol Use Disorder AUD. This trial aims to evaluate whether CBD can improve symptoms such as anxiety, sleep problems, and seizures that commonly occur during alcohol withdrawal. The study also explores if CBD can reduce the need for benzodiazepines, which are standard but sometimes risky treatments for withdrawal. The trial is randomized and placebo-controlled, conducted by Johns Hopkins University. Participants are admitted to an inpatient research unit for a 5-day, 4-night stay to undergo alcohol abstinence and withdrawal management. Alongside standard care, participants receive either a placebo or one of two oral doses of CBD 10 mgkg or 20 mgkg. Withdrawal symptoms are monitored multiple times daily using standardized tools, and symptom-triggered lorazepam is administered as needed. Sleep quality is assessed by sleep diaries and wrist actigraphy, while alcohol cravings are measured through questionnaires taken four times daily during the inpatient stay. During the study, participants complete various assessments including breath and blood samples, and their alcohol withdrawal symptoms, sleep quality, and cravings are tracked closely. Researchers measure primary outcomes such as peak withdrawal scores and sleep duration during the 4-night stay, alongside secondary outcomes like lorazepam use and liver enzyme levels. The study is designed to provide detailed insights into the effects of CBD on withdrawal and craving, with the potential to inform future outpatient treatments.
CONDITIONS
Brief Title
Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving
Research Team
D
David Woliinsky, MD
E
Elise M Weerts, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here